Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12589171 | 177-Lu labeled peptide for site-specific uPAR-targeting | 🖼🧊📄§ | 2026-03-31 | 2041-01-07 | 0 | 31 |
| 12589182 | Occlusive implant compositions | 🖼🧊📄§ | 2026-03-31 | 2043-12-29 | 0 | 31 |
| 12589075 | Osmotic dosage forms comprising deutetrabenazine and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2044-03-19 | 0 | 31 |
| 12589074 | Tablets having discontinuous coated regions | 🖼🧊📄§ | 2026-03-31 | 2043-01-05 | 0 | 31 |
| 12589073 | Leveraging lipid-protein interactions to engineer spatial organization in cell-free systems | 🖼🧊📄§ | 2026-03-31 | 2042-11-09 | 0 | 31 |
| 12589066 | Cosmetic composition containing an extract from opuntia ficus indica | 🖼🧊📄§ | 2026-03-31 | 2040-11-02 | 0 | 31 |
| 12589065 | Hair care system, hair care method and use of a hair care system | 🖼🧊📄§ | 2026-03-31 | 2039-01-17 | 0 | 31 |
| 12589069 | Ophthalmic suspension composition | 🖼🧊📄§ | 2026-03-31 | 2042-12-21 | 0 | 31 |
| 12589071 | Suckable and/or melt-in-mouth tablet based on hyaluronic acid and chondroitin sulphate and salts thereof | 🖼🧊📄§ | 2026-03-31 | 2044-02-26 | 0 | 31 |
| 12589068 | Contraceptive medical devices | 🖼🧊📄§ | 2026-03-31 | 2040-11-11 | 0 | 31 |
| 12589072 | Bioadhesive film and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2041-11-11 | 0 | 31 |
| 12589057 | Cosmetic composition of liquid crystal lipid particles for personal care applications | 🖼🧊📄§ | 2026-03-31 | 2040-01-27 | 0 | 31 |
| 12589055 | Dental composition | 🖼🧊📄§ | 2026-03-31 | 2040-09-10 | 0 | 31 |
| 12588675 | Synergistic antibacterial activity of medium polarity oils in combination with antibacterial agents on bacterial biofilms | 🖼🧊📄§ | 2026-03-31 | 2043-04-03 | 0 | 31 |
| 12588689 | Feed additive composition containing erythritol | 🖼🧊📄§ | 2026-03-31 | 2041-09-07 | 0 | 31 |
| 12588863 | Systems and methods for preventing and treating wrinkles | 🖼🧊📄§ | 2026-03-31 | 2044-05-15 | 0 | 31 |
| 12590134 | GLP-1 agonist polypeptide compound and salt thereof, synthesis method therefor and use thereof | 🖼🧊📄§ | 2026-03-31 | 2042-08-17 | 0 | 31 |
| 12590129 | Liver-specific regulatory nucleic acid sequences | 🖼🧊📄§ | 2026-03-31 | 2039-11-19 | 0 | 31 |
| 12590153 | Treatment of PD-L1-negative melanoma using an anti-PD-1 antibody and an anti-CTLA-4 antibody | 🖼🧊📄§ | 2026-03-31 | 2041-11-10 | 0 | 31 |
| 12582650 | IRAK4 kinase inhibitor and preparation method therefor | 🖼🧊📄§ | 2026-03-24 | 2040-07-24 | 0 | 31 |
| 12582610 | Lipid-polymer compositions and methods of use | 🖼🧊📄§ | 2026-03-24 | 2043-07-18 | 0 | 31 |
| 12582597 | Wax of natural origin for cosmetic products | 🖼🧊📄§ | 2026-03-24 | 2043-05-05 | 0 | 31 |
| 12582724 | Compositions comprising microbial polypeptides for degrading glycogen and methods for the treatment of glycogen storage diseases | 🖼🧊📄§ | 2026-03-24 | 2040-02-20 | 0 | 31 |
| 12582611 | Lipid nanoparticle compositions and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2044-03-01 | 0 | 31 |
| 12582702 | Methods for improving leptin sensitivity for the treatment of obesity and diabetes | 🖼🧊📄§ | 2026-03-24 | 2039-05-09 | 0 | 31 |
| 12582664 | Treatment of fragile x syndrome with cannabidiol | 🖼🧊📄§ | 2026-03-24 | 2042-10-20 | 0 | 31 |
| 12583937 | Compositions and methods for the diagnosis and treatment of tumor | 🖼🧊📄§ | 2026-03-24 | 2042-03-16 | 0 | 31 |
| 12582589 | Compositions and methods for eyelashes | 🖼🧊📄§ | 2026-03-24 | 2040-12-22 | 0 | 31 |
| 12582716 | Stable, aqueous formulations of antibodies that bind IL5 receptor | 🖼🧊📄§ | 2026-03-24 | 2039-03-11 | 0 | 31 |
| 12583929 | Method of treating acute respiratory distress syndrome | 🖼🧊📄§ | 2026-03-24 | 2041-06-07 | 0 | 31 |
| 12583895 | Polypeptides for restoring endothelial function and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-02-12 | 0 | 31 |
| 12584904 | Methods for monitoring physiological status of a body organ | 🖼🧊📄§ | 2026-03-24 | 2042-11-22 | 0 | 31 |
| 12584147 | Rational polyploid adeno-associated virus vectors for the treatment of disease | 🖼🧊📄§ | 2026-03-24 | 2043-05-19 | 0 | 31 |
| 12584174 | Treatment of psoriasis with interferon induced Helicase C domain 1 (IFIH1) inhibitors | 🖼🧊📄§ | 2026-03-24 | 2042-06-09 | 0 | 31 |
| 12584138 | Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies | 🖼🧊📄§ | 2026-03-24 | 2041-08-26 | 0 | 31 |
| 12584131 | Methods of gene therapy | 🖼🧊📄§ | 2026-03-24 | 2039-04-30 | 0 | 31 |
| 12584110 | Functional feline pancreatic cells from adipose tissue | 🖼🧊📄§ | 2026-03-24 | 2043-09-22 | 0 | 31 |
| 12584118 | Cas9 variants and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2042-09-30 | 0 | 31 |
| 12583902 | DNA-binding domain transactivators and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2040-02-24 | 0 | 31 |
| 12583898 | Therapeutic interferon alpha 1 proteins | 🖼🧊📄§ | 2026-03-24 | 2042-07-21 | 0 | 31 |
| 12583903 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | 🖼🧊📄§ | 2026-03-24 | 2042-06-03 | 0 | 31 |
| 12583910 | T cell antigen receptor, multimeric complex thereof, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-24 | 2041-04-23 | 0 | 31 |
| 12583905 | Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells | 🖼🧊📄§ | 2026-03-24 | 2044-11-20 | 0 | 31 |
| 12583908 | Albumin protein variants, production thereof and uses of same | 🖼🧊📄§ | 2026-03-24 | 2045-01-16 | 0 | 31 |
| 12583916 | Methods to improve glucose tolerance in a subject by administering an antibody that binds to extracellular human metallothionein 1A (MT1A) | 🖼🧊📄§ | 2026-03-24 | 2043-07-24 | 0 | 31 |
| 12583914 | Methods of treating allergy using anti-bet v 1 antibodies | 🖼🧊📄§ | 2026-03-24 | 2043-12-19 | 0 | 31 |
| 12583920 | Compositions and methods for treatment and prevention of Alzheimer's disease | 🖼🧊📄§ | 2026-03-24 | 2042-04-03 | 0 | 31 |
| 12583922 | Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2042-03-22 | 0 | 31 |
| 12583927 | Anti-variable MUC1* antibodies and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2041-07-12 | 0 | 31 |
| 12583928 | Antibodies against IGFR-like receptor and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2042-02-24 | 0 | 31 |